Lidoderm Buyers, Payors Near Cert. In Pay-For-Delay MDL
A California federal judge indicated Tuesday he's inclined to certify a putative class of indirect drug buyers and a class of end-payors in a pay-for-delay multidistrict litigation against Endo Pharmaceuticals and...To view the full article, register now.
Already a subscriber? Click here to view full article